Immunic, Inc. (IMUX) vs Vivani Medical, Inc. (VANI)

A side-by-side comparison of Immunic, Inc. and Vivani Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IMUX vs VANI

growth of $100 · dividends reinvested · last 10y
IMUX -99.7% (-43.5%/yr)VANI -98.4% (-34.0%/yr)VANI compounded faster over this window
050100150Start $10020182020202220242026$0$2
IMUX VANI

IMUX vs VANI: by the numbers

  • •VANI is the larger company ($107M vs $107M market cap).

Metrics side by side

Valuation

MetricIMUXVANI
P/B ratio0.835.64

Profitability

MetricIMUXVANI
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-87.45%-138.73%
ROIC-92.16%-73.94%

Growth (annualized)

MetricIMUXVANI
Total return CAGR (5Y)-35.70%-32.72%

Frequently asked

How have IMUX and VANI total returns compared?
Over the past 10 years, IMUX delivered -43.80% and VANI delivered -34.24% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.